Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Triple Sealed: Induction seal, click-tight lid, and shrink wrapping for maximum protection
The lone Phase I trials silence is concerning
However, existing studies have not confirmed any increase in cancer risk from epitalon
What the evidence shows Consistency across studies: a systematic review spanning 36 studies from 1993 to 2024 found reliable evidence of structural and functional recovery across tendon, ligament, muscle, and bone injury models, with no adverse effects reported at any dose tested, a notably clean safety signal given the study volume (Vasireddi et al., 2025) A specific mechanism in tendon repair: preclinical work found BPC-157 upregulates growth hormone receptor expression in tendon fibroblasts specifically, pointing to a plausible pathway for its effects on connective tissue (Chang et al., 2018) Reach beyond the musculoskeletal system: research has extended into the gut, liver, and cardiovascular system, suggesting the cytoprotective activity isnt confined to one tissue type but reflects a broader mechanism (Jozwiak et al., 2025) For research use only
Daniel Culver of the Cleveland Clinic, stated that the magnitude of effect in only 28 days was remarkable and suggested cibinetide has the potential to become a transformative disease-modifying therapy
